1. Which of the following is the most common type of kidney stone seen in the general population:
A. Calcium
B. Uric acid
C. Struvite
D. Cystine
2. When kidney stones start to develop there are many different changes that occur. Which of the following changes in the urine explains why kidney stones can develop in the kidney or ureter:
A. Solubility and precipitation of salts become balanced
B. Increased urine output caused by excessive fluid intake
C. Increased urination because of the use of a thiazide diuretic
D. Insoluble materials become supersaturated
3. Which of the following chronic medical conditions can increase the risk of kidney stone disease:
A. Hypertension
B. Type 2 Diabetes
C. Osteoporosis
D. Chronic Obstructive Pulmonary Disease (COPD)
4. Of the following dietary eating patterns, which can increases risk of stone formation:
A. High fluid intake
B. High ingestion of citric acid based drinks
C. Low intake of animal protein
D. Low intake of calcium foods
5. A man, 50 years of age, with a history of hypertension, dyslipidemia, and diabetes is vacationing in the Colorado Rocky Mountains. His current medications are metformin, atorvastatin, and hydrochlorothiazide. He starts taking acetazolamide to prevent altitude sickness the day prior to his vacation. After 5 days, he is diagnosed with a kidney stone. Which of the following medications was a risk factor for this patient developing acute kidney stone disease:
A. Acetazolamide
B. Atorvastatin
C. Hydrochlorothiazide
D. Metformin
6. Which of the following drugs is most effective when used in medical expulsive therapy (MET) for the treatment of kidney stones:
A. Carvediolol
B. Doxazosin
C. Tamsulosin
D. Terazosin
7. Which of the following is the most appropriate first-line treatment for a patient with an 8 mm calcium oxalate stone who has well-controlled symptoms?
A. MET
B. Shock-wave lithotripsy (SWL)
C. Ureteroscopy
D. No therapy because the stone should pass on its own
8. A woman has a history of recurrent calcium stones. Which of the following diuretics is most effective for preventing the recurrence of stone formation in this patient:
A. Chlorthalidone 25 mg daily
B. Furosemide 20 mg twice daily
C. Hydrochlorothiazide 12.5 mg daily
D. Spironolactone 25 mg daily
9. Allopurinol is effective for minimizing stone recurrence in patients with which of the following characteristics:
A. Obesity
B. Type 2 diabetes
C. Hyperuricosuria
D. Struvite-type stones
10. Which of the following treatments is effective for decreasing stone recurrence:
A. Potassium citrate for calcium oxalate stones
B. Tiopronin for cysteine stones
C. Acetohydroxamic acid for struvite stones
D. All of the above are effective treatment for the stated stone type
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology/Specialty Pharmacy
I. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
